Medical Toxicology Expert Witnesses in West Virginia

This highly-qualified expert has her Masters, PhD and postdoctoral training in the area of environmental toxicology. She continues to work in this area, focusing primarily on the long term effects following exposures to halogenated hydrocarbons. In addition, her research activities involve the study of drug metabolism and nuclear hormone receptors. Her teaching activities (to dental, medical, graduate and undergraduate students), encompass the disciplines of toxicology and pharmacology. The focus here is understanding how exposures to certain chemicals (drugs or toxicants) elicit specific effects resulting in either therapeutic benefit or damage to certain tissues and how that impacts overall health.

This expert has been practicing toxicology for over 40 years. She holds a Master of Science in Clinical Chemistry as well as a Ph.D. in Toxicology, and an honorary doctoral degree in Medicine and Surgery from the Faculty of Medicine, University of Helsinki. She serves on the World Anti-Doping Agency's Prohibited List Committee, the National Commission on Forensic Sciences, the Organization of Scientific Area Committee on Toxicology, Transportation Research Board Committee on Alcohol and Other Drugs, and the National Safety Council's Alcohol, Drugs and Impairment Division Executive Board. She was a President of the International Association of Forensic Toxicologists, she is also a former President of the Society of Forensic Toxicologist and past Chair of the Toxicology Section of the American Academy of Forensic Sciences. She has published over 445 peer-reviewed articles and has presented more than 500 abstracts at national and international meetings, and she sits on the Editorial Board of multiple toxicological and chemical journals. She recently retired as Chief of Chemistry and Drug Metabolism, National Institute on Drug Abuse, National Institutes of Health. She serves as an Adjunct Professor at a major medical university. She consults with the US Department of Transportation, NMS Labs, and other diagnostic companies around the world. The journal Clinical Chemistry identified her as an inspiring mind.

This clinical development and regulatory expert has an M.S and Ph.D. in Pharmacology & Toxicology from West Virginia University. A member of the American Society of Clinical Pharmacology & Therapeutics, he has extensive product development experience in the pharmaceutical field. The expert spent his early career in clinical research roles, including a position as the Director of Clinical Research Operations for Univax Biologics. He has since founded/run a biotech development business and acts as both a Professor and Consultant in his field.

This highly qualified expert is specialized in the color and cosmetics chemistry with a deep understanding of formulation, toxicology, microbiology, and the safety requirements of products within his field. He spent 34 years with the Food and Drug Administration where he held a number of positions including serving as the chief of color technology, deputy director of color and cosmetics, and director of applied research and safety assessment at CFSAN. He also served as the director of cosmetic chemistry at The Cosmetic, Toiletry and Fragrance Association and as the executive vice president of science at The Personal Care Products Council. Currently, this expert is an independent advisor of a consulting group in Virginia.

This highly-qualified expert has nearly 45 years of experience in pharmacology. He specializes in pediatric clinical pharmacology, toxicology, and clinical pharmacy, as well as adverse drug reactions, drug-drug-food interactions, pharmacokinetics-pharmacodynamics, and pharmacogenomics. He earned both his BS in pharmacy and his PharmD from the University of Cincinnati. He also completed an internship in community pharmacy at Winston Place Pharmacy, an internship in hospital pharmacy at Holmes Hospital, and a residency in pediatric clinical pharmacy and clinical pharmacology at Children's Hospital Medical Center. This expert is board certified in applied pharmacology by the American Board of Clinical Pharmacology. He is active in his field as a member of the American Society of Hospital Pharmacists and the American College of Clinical Pharmacology. He has formerly served as the co-director of pediatric clinical pharmacology and toxicology at Rainbow Babies and Children's Hospital and the director of the clinical research center at Akron Children's Hospital. Additionally, he has held a variety of teaching positions, including as a tenured professor of pediatrics in the division of pediatric pharmacology and critical care at Case Western Reserve University and as a professor of pediatrics at Northeast Ohio Medical University. Currently, this expert is a professor emeritus of pediatrics at an Ohio university.

This expert holds a doctorate degree in toxicology and has been a practicing toxicologist for over 40 years. Board certified by the American Board of Toxicology and a Fellow of the Academy of Toxicological Sciences, he had published over 35 scientific articles and is a former president of the Mid-Atlantic chapter of the Society of Toxicology. He spent over 30 years as a Director of Toxicology for two major pharmaceutical companies and currently serves as an independent toxicology consultant.

This expert is board certified psychiatrist and addiction specialist, and also is certified by the American Board of Disability Analysts. He is an expert in handling capital, personal injury, loss mitigation, malpractice and negligence cases that involve the use of abused substances (especially, opiates, alcohol, hallucinogens, and stimulants), prescribed pharmacological agents, and in the general field of psychiatric and brain disease. This expert also is a leading neuroscientist and neuropsychopharmacologist. He can provide expert testimony on the effects of different brain states and function, in both health and disease, and their potential association with with legal culpability and liability. He currently serves as the Chairman of the Department of Psychiatry at a leading university in the USA, and has over 12 years experience as Chairman in Psychiatry Departments in the USA. His research focus is in the neuropsychopharmacology of addiction, addiction and pain, pain treatment, impact of genetics on human behavior, the basic, molecular, and the brain imaging sciences related to the functioning of the brain in health, disease and addiction. In recognition of his academic, scholarly and professional achievement, he is a Fellow of the Collegium Internationale Neuro-psychopharmacologicum and a Distinguished Fellow of the American Psychiatric Association. He is the recipient of numerous professional and scientific awards, including the Jack Mendelson Award at the NIH, which is awarded to individuals who have made distinguished contributions to our understanding of the science of addiction. He has an h-index of 46, and 11829 citations of his published work.